Results 161 to 170 of about 4,768 (212)

Leading prodrug strategies for targeted and specific release. [PDF]

Future Med Chem
Bargakshatriya R, Pramanik SK.
europepmc   +1 more source

Mimicry of inherited red cell disorders: the result of somatic mutations in a clonal myeloid disease. [PDF]

Haematologica
Lichtman MA, Jajosky AN.
europepmc   +1 more source

Organelle regulation of ferroptosis after intracerebral hemorrhage. [PDF]

Redox Biol
Zhou N, Du Y, Wang Y, Zhao X, Ju Y.
europepmc   +1 more source

Enhanced heme production in industrial Saccharomyces cerevisiae through metabolic engineering. [PDF]

NPJ Sci Food
Lee HJ, Lee TG, Cho C, Jeon GB, Oh S, Kim SK.   +5 more
europepmc   +1 more source

Updates to gene-disease classifications and inheritance patterns for porphyrias. [PDF]

Mol Genet Metab
Reeves EB, Hankey W, Clair PS, Goldstein JL, Wilke MVMB, Feigenbaum A, Hung C, Spector E, Craigen WJ.   +8 more
europepmc   +1 more source

Redox status regulates eggshell color by modulating protoporphyrin IX biosynthesis via the SIRT1/PGC-1α/ALAS1 axis in brown-shelled hens. [PDF]

J Anim Sci Biotechnol
Fu Y, Lu M, Liu D, Wang J, Zhang H, Qi G, Wang J.   +6 more
europepmc   +1 more source

Structural and mechanistic basis of porphyrin metallation by ferrochelatase

Journal of Molecular Biology, 2000
Ferrochelatase, the enzyme catalyzing metallation of protoporphyrin IX at the terminal step of heme biosynthesis, was co-crystallized with an isomer mixture of the potent inhibitor N-methylmesoporphyrin (N-MeMP).
Michel Fodje, A Hansson, Mats Hansson
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

A simple ferrochelatase assay

Biochimie, 1981
Jean-Michel Camadro, Pierre Labbé
exaly   +3 more sources